PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 91 filers reported holding PORTOLA PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $5,527,000 | +122.2% | 307,215 | -11.9% | 0.00% | 0.0% |
| Q1 2020 | $2,487,000 | -66.6% | 348,810 | +11.7% | 0.00% | -50.0% |
| Q4 2019 | $7,457,000 | -9.9% | 312,249 | +1.2% | 0.00% | 0.0% |
| Q3 2019 | $8,275,000 | +9.8% | 308,541 | +11.0% | 0.00% | 0.0% |
| Q2 2019 | $7,539,000 | -24.2% | 277,891 | -3.1% | 0.00% | -33.3% |
| Q1 2019 | $9,949,000 | +77.0% | 286,730 | -0.4% | 0.00% | +50.0% |
| Q4 2018 | $5,622,000 | -43.6% | 288,014 | -23.0% | 0.00% | -33.3% |
| Q3 2018 | $9,964,000 | -33.4% | 374,219 | -5.5% | 0.00% | -25.0% |
| Q2 2018 | $14,964,000 | +15.3% | 396,163 | -0.3% | 0.00% | 0.0% |
| Q1 2018 | $12,983,000 | -29.4% | 397,532 | +5.2% | 0.00% | -20.0% |
| Q4 2017 | $18,402,000 | +2.0% | 378,006 | +13.2% | 0.01% | 0.0% |
| Q3 2017 | $18,045,000 | +15.7% | 334,027 | +20.3% | 0.01% | +25.0% |
| Q2 2017 | $15,596,000 | +58.7% | 277,642 | +10.7% | 0.00% | +33.3% |
| Q1 2017 | $9,825,000 | +88.3% | 250,723 | +7.8% | 0.00% | +50.0% |
| Q4 2016 | $5,218,000 | +3.1% | 232,512 | +4.3% | 0.00% | 0.0% |
| Q3 2016 | $5,062,000 | -15.4% | 222,903 | -12.1% | 0.00% | 0.0% |
| Q2 2016 | $5,986,000 | +17.4% | 253,641 | +1.5% | 0.00% | 0.0% |
| Q1 2016 | $5,099,000 | -66.4% | 249,949 | -15.4% | 0.00% | -60.0% |
| Q4 2015 | $15,194,000 | +34.2% | 295,316 | +11.2% | 0.01% | +66.7% |
| Q3 2015 | $11,322,000 | -5.9% | 265,641 | +0.5% | 0.00% | 0.0% |
| Q2 2015 | $12,037,000 | +26.7% | 264,273 | +5.6% | 0.00% | +50.0% |
| Q1 2015 | $9,502,000 | +49.9% | 250,318 | +11.9% | 0.00% | 0.0% |
| Q4 2014 | $6,338,000 | +9.1% | 223,795 | -2.6% | 0.00% | 0.0% |
| Q3 2014 | $5,810,000 | -46.9% | 229,822 | -38.7% | 0.00% | +100.0% |
| Q2 2014 | $10,938,000 | +311.4% | 374,858 | +265.1% | 0.00% | 0.0% |
| Q1 2014 | $2,659,000 | +4.2% | 102,661 | +3.6% | 0.00% | 0.0% |
| Q4 2013 | $2,553,000 | +13.7% | 99,123 | +18.0% | 0.00% | – |
| Q3 2013 | $2,246,000 | +92.6% | 84,014 | +77.0% | 0.00% | – |
| Q2 2013 | $1,166,000 | – | 47,456 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Grace Capital | 270,832 | $6,467,000 | 5.27% |
| Fernwood Investment Management, LLC | 336,111 | $8,026,000 | 3.84% |
| Tamarack Advisers, LP | 595,000 | $14,268,000 | 3.26% |
| First Light Asset Management, LLC | 1,008,957 | $24,094,000 | 3.08% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 1,540,679 | $36,791,000 | 2.79% |
| CADIAN CAPITAL MANAGEMENT, LP | 2,133,343 | $50,944,000 | 2.25% |
| SECTORAL ASSET MANAGEMENT INC | 606,189 | $14,476,000 | 2.16% |
| Asymmetry Capital Management, L.P. | 49,431 | $1,180,000 | 2.12% |
| Parkman Healthcare Partners LLC | 275,505 | $6,579,000 | 1.90% |
| HARVEY CAPITAL MANAGEMENT INC | 150,751 | $3,599,000 | 1.60% |